Page last updated: 2024-12-10
methylserine phosphate
Cross-References
| ID Source | ID |
|---|
| PubMed CID | 3964633 |
| CHEMBL ID | 1437137 |
| SCHEMBL ID | 13184575 |
| MeSH ID | M0332406 |
Synonyms (20)
| Synonym |
|---|
| gtpl1398 |
| alpha-msop |
| alpha-methylserine-o-phosphate |
| msop |
| NCGC00024799-02 |
| L000819 |
| AKOS006275016 |
| 2-amino-2-methyl-3-phosphonooxypropanoic acid |
| (rs)-alpha-methylserine-o-phosphate |
| 66515-29-5 |
| SCHEMBL13184575 |
| CHEMBL1437137 |
| (rs)-?-methylserine-o-phosphate |
| DTXSID40398271 |
| sr-01000597443 |
| SR-01000597443-1 |
| 2-amino-2-methyl-3-(phosphonooxy)propanoic acid |
| Q27074406 |
| CS-0021013 |
| HY-101226 |
Protein Targets (2)
Potency Measurements
Bioassays (6)
| Assay ID | Title | Year | Journal | Article |
|---|
| AID1347154 | Primary screen GU AMC qHTS for Zika virus inhibitors | 2020 | Proceedings of the National Academy of Sciences of the United States of America, 12-08, Volume: 117, Issue:49
| Therapeutic candidates for the Zika virus identified by a high-throughput screen for Zika protease inhibitors. |
| AID1508630 | Primary qHTS for small molecule stabilizers of the endoplasmic reticulum resident proteome: Secreted ER Calcium Modulated Protein (SERCaMP) assay | 2021 | Cell reports, 04-27, Volume: 35, Issue:4
| A target-agnostic screen identifies approved drugs to stabilize the endoplasmic reticulum-resident proteome. |
| AID1346263 | Human mGlu7 receptor (Metabotropic glutamate receptors) | 2000 | Naunyn-Schmiedeberg's archives of pharmacology, Dec, Volume: 362, Issue:6
| Binding of [3H](2S,1'S,2'S)-2-(9-xanthylmethyl)-2-(2'-carboxycyclopropyl) glycine ([3H]LY341495) to cell membranes expressing recombinant human group III metabotropic glutamate receptor subtypes. |
| AID1346251 | Rat mGlu8 receptor (Metabotropic glutamate receptors) | 2002 | Current drug targets. CNS and neurological disorders, Jun, Volume: 1, Issue:3
| The metabotropic glutamate receptors: structure, activation mechanism and pharmacology. |
| AID1346287 | Rat mGlu2 receptor (Metabotropic glutamate receptors) | 1998 | British journal of pharmacology, Feb, Volume: 123, Issue:3
| Characterization of [3H]-(2S,2'R,3'R)-2-(2',3'-dicarboxy-cyclopropyl)glycine ([3H]-DCG IV) binding to metabotropic mGlu2 receptor-transfected cell membranes. |
| AID1346255 | Rat mGlu6 receptor (Metabotropic glutamate receptors) | 2002 | Current drug targets. CNS and neurological disorders, Jun, Volume: 1, Issue:3
| The metabotropic glutamate receptors: structure, activation mechanism and pharmacology. |
| [information is prepared from bioassay data collected from National Library of Medicine (NLM), extracted Dec-2023] |
Research
Studies (5)
| Timeframe | Studies, This Drug (%) | All Drugs % |
|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 1 (20.00) | 18.2507 |
| 2000's | 2 (40.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 2 (40.00) | 2.80 |
| [information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023] |
Market Indicators
Research Demand Index: 12.94
According to the monthly volume, diversity, and competition of internet searches for this compound, as well the volume and growth of publications, there is estimated to be weak demand-to-supply ratio for research on this compound.
| Metric | This Compound (vs All) |
|---|
| Research Demand Index | 12.94 (24.57) | | Research Supply Index | 1.79 (2.92) | | Research Growth Index | 4.73 (4.65) | | Search Engine Demand Index | 0.00 (26.88) | | Search Engine Supply Index | 0.00 (0.95) |
| |
Study Types
| Publication Type | This drug (%) | All Drugs (%) |
|---|
| Trials | 0 (0.00%) | 5.53% |
| Reviews | 1 (20.00%) | 6.00% |
| Case Studies | 0 (0.00%) | 4.05% |
| Observational | 0 (0.00%) | 0.25% |
| Other | 4 (80.00%) | 84.16% |
| [information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023] |